ArticleAnnals of translational medicine2023
The role of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Jorge Avila et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.